Ken-Ichi Inoue Selected Research

Ken-Ichi Inoue Research Topics

Disease

7	Rabies (Hydrophobia) 01/2022 - 04/2005
4	Inflammation (Inflammations) 11/2023 - 01/2016
4	Neoplasms (Cancer) 11/2023 - 11/2011
3	Obesity 11/2023 - 05/2021
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2016
2	Atherosclerosis 01/2023 - 05/2021
2	Stress Urinary Incontinence 10/2022 - 06/2018
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2022 - 01/2017
2	Vesicular Stomatitis 01/2021 - 01/2019
2	Ischemia 01/2020 - 01/2016
2	Wounds and Injuries (Trauma) 01/2020 - 06/2018
1	Hypertension (High Blood Pressure) 11/2023
1	Thrombosis (Thrombus) 11/2023
1	Atrial Fibrillation 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Vascular System Injuries 01/2023
1	Dermatitis 12/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Epilepsy (Aura) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Hyperplasia 01/2022
1	Hyperphagia (Overeating) 10/2021
1	Hyperglycemia 10/2021
1	Overweight 05/2021
1	Acute Coronary Syndrome 01/2021
1	Myasthenia Gravis 01/2020
1	Neonatal Myasthenia Gravis (Transient Neonatal Myasthenia Gravis) 01/2020
1	Hypoxia (Hypoxemia) 07/2019
1	Muscle Rigidity 01/2019
1	MPTP Poisoning 01/2019
1	Hypokinesia (Bradykinesia) 01/2019
1	Carcinoma (Carcinomatosis) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 08/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Insulinoma 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Neuroblastoma 11/2011

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	Designer DrugsIBA 01/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 08/2016
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2019
1	ChalconesIBA 11/2023
1	erucylphosphocholineIBA 01/2023
1	RivaroxabanIBA 01/2023
1	Factor Xa InhibitorsIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	Warfarin (Coumadin)FDA LinkGeneric 01/2023
1	BicucullineIBA 01/2023
1	Interleukin-9 (Interleukin 9)IBA 12/2022
1	Imiquimod (Aldara)FDA LinkGeneric 12/2022
1	Neuropeptide YIBA 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	Peptide YYIBA 12/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	FructoseIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	LeptinIBA 10/2021
1	ApolipoproteinsIBA 05/2021
1	CholesterolIBA 05/2021
1	Apolipoproteins E (ApoE)IBA 05/2021
1	muskIBA 01/2020
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 07/2019
1	Fluorouracil (Carac)FDA LinkGeneric 07/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	CalbindinsIBA 01/2019
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2019
1	PteridinesIBA 01/2018
1	NF-E2-Related Factor 2IBA 08/2016
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	Protamines (Protamine Sulfate)FDA Link 01/2016
1	ThioredoxinsIBA 01/2016
1	Thioredoxin-Disulfide ReductaseIBA 01/2016
1	Auranofin (Ridaura)FDA Link 01/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	piperlongumineIBA 01/2016
1	Core Binding Factor Alpha 3 SubunitIBA 11/2011
1	Messenger RNA (mRNA)IBA 11/2011
1	Proteins (Proteins, Gene)FDA Link 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011

Therapy/Procedure

6	Injections 01/2022 - 01/2012
1	Percutaneous Coronary Intervention 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022
1	Therapeutics 01/2022
1	Stents 01/2021
1	Operative Surgical Procedures 01/2020
1	Transplantation 06/2018
1	Heterotopic Transplantation 06/2018
1	Ligation 01/2016